A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.
This study has been withdrawn prior to enrollment.
(This study was Cancelled Before Active)
Information provided by (Responsible Party):
First received: September 22, 2011
Last updated: July 24, 2014
Last verified: July 2014
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Estimated Study Completion Date:||April 2015|
|Estimated Primary Completion Date:||April 2015 (Final data collection date for primary outcome measure)|